Indication

Peanut allergy

Peanut allergy is an immunoglobulin E (IgE)–mediated hypersensitivity disorder triggered by exposure to proteins found in peanuts (*Arachis hypogaea*). Read more about Peanut allergy

14 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Peanut allergy therapies.

Showing 1–9 of 14 drugs

Filter & compare in the drug finder →Opens the drug finder with Peanut allergy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Peanut allergy.

Peanut allergy is an immunoglobulin E (IgE)–mediated hypersensitivity disorder triggered by exposure to proteins found in peanuts (*Arachis hypogaea*).

Primarily affecting children but often persisting lifelong into adulthood, it engages the immune system and multiple organ systems, including the cutaneous, gastrointestinal, respiratory, and cardiovascular tracts.

Exposure leads to rapid cross-linking of allergen-specific IgE on mast cells and basophils, resulting in systemic release of inflammatory mediators.

Clinically, reactions range from acute urticaria, angioedema, pruritus, and vomiting to severe, potentially fatal respiratory compromise, vascular collapse, and systemic anaphylaxis.

Personalize your experience

Follow Peanut allergy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it